{"id":1037540,"date":"2017-03-22T10:43:36","date_gmt":"2017-03-22T14:43:36","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/uncategorized\/biotechnology-gets-a-shot-in-the-arm-barrons-blog.php"},"modified":"2024-08-17T16:07:47","modified_gmt":"2024-08-17T20:07:47","slug":"biotechnology-gets-a-shot-in-the-arm-barrons-blog","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/biotechnology\/biotechnology-gets-a-shot-in-the-arm-barrons-blog.php","title":{"rendered":"Biotechnology Gets A Shot In the Arm &#8211; Barron&#8217;s (blog)"},"content":{"rendered":"<table border=\"0\" cellpadding=\"2\" cellspacing=\"7\" style=\"vertical-align:top;\"><tr><td width=\"80\" align=\"center\" valign=\"top\"><font style=\"font-size:85%;font-family:arial,sans-serif\"><\/font><\/td><td valign=\"top\" class=\"j\"><font style=\"font-size:85%;font-family:arial,sans-serif\"><div style=\"padding-top:0.8em;\"><img alt=\"\" height=\"1\" width=\"1\" style=\"padding-left:10px; padding-right: 10px;\"><\/div><div class=\"lh\"><a href=\"http:\/\/news.google.com\/news\/url?sa=t&amp;fd=R&amp;ct2=us&amp;usg=AFQjCNFkVCK-uGv2WzTv1-1eW9XloHq-5g&amp;clid=c3a7d30bb8a4878e06b80cf16b898331&amp;cid=52779431370949&amp;ei=ZY3SWOCqEY7M3QHHpb2IBw&amp;url=http:\/\/blogs.barrons.com\/focusonfunds\/2017\/03\/21\/biotechnology-gets-a-shot-in-the-arm\/\"><b><b>Biotechnology<\/b> Gets A Shot In the Arm<\/b><\/a><br><font size=\"-1\"><b><font color=\"#6f6f6f\">Barron's (blog)<\/font><\/b><\/font><br><font size=\"-1\">Consider iShares Nasdaq <b>Biotechnology<\/b> (IBB) and the SPDR S&amp;P Biotech (XBI). IBB has a bigger swath of the sector with 162 constituents in the index that it tracks, while XBI has 87. IBB's top holdings are in large-caps such as Celgene (CELG) and Gilead&nbsp;...<\/font><br><font size=\"-1\"><a href=\"http:\/\/news.google.com\/news\/url?sa=t&amp;fd=R&amp;ct2=us&amp;usg=AFQjCNHf0VA0Q8n_hB6xnEgn2yu_9Y-4pA&amp;clid=c3a7d30bb8a4878e06b80cf16b898331&amp;cid=52779431370949&amp;ei=ZY3SWOCqEY7M3QHHpb2IBw&amp;url=https:\/\/www.streetinsider.com\/Options\/iShares%2BNasdaq%2BBiotechnology%2B(IBB)%2Bvolatility%2Blow%2Binto%2BCredit%2BSuisse%2Bupgrade%2Bfrom%2BMarket%2BWeight%2Bto%2BOverweight\/12690239.html\">iShares Nasdaq Biotechnology (IBB) volatility low into Credit Suisse ...<\/a><font size=\"-1\" color=\"#6f6f6f\"><nobr>StreetInsider.com<\/nobr><\/font><\/font><br><font size=\"-1\"><a href=\"http:\/\/news.google.com\/news\/url?sa=t&amp;fd=R&amp;ct2=us&amp;usg=AFQjCNGgn1cdeJGc_bpEwj1HzlAcqyfbqA&amp;clid=c3a7d30bb8a4878e06b80cf16b898331&amp;cid=52779431370949&amp;ei=ZY3SWOCqEY7M3QHHpb2IBw&amp;url=https:\/\/baseballnewssource.com\/markets\/ishares-nasdaq-biotechnology-index-ibb-rating-increased-to-overweight-at-credit-suisse-group-ag\/519403.html\">iShares NASDAQ Biotechnology Index (IBB) Rating Increased to ...<\/a><font size=\"-1\" color=\"#6f6f6f\"><nobr>BBNS<\/nobr><\/font><\/font><br><font size=\"-1\" class=\"p\"><\/font><br><font class=\"p\" size=\"-1\"><a class=\"p\" href=\"http:\/\/news.google.com\/news\/more?ncl=dgJvjfdwIxnB5HMrJ4tAkJ0aJCr-M&amp;authuser=0&amp;ned=us\"><nobr><b>all 5 news articles&nbsp;&raquo;<\/b><\/nobr><\/a><\/font><\/div><p><\/p><\/font><\/td><\/tr><\/table><p><!-- Auto Generated --><\/p><p>Original post:<br><a target=\"_blank\" href=\"http:\/\/blogs.barrons.com\/focusonfunds\/2017\/03\/21\/biotechnology-gets-a-shot-in-the-arm\/\" title=\"Biotechnology Gets A Shot In the Arm - Barron's (blog)\" rel=\"noopener\">Biotechnology Gets A Shot In the Arm - Barron's (blog)<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p> Biotechnology Gets A Shot In the Arm Barron's (blog) Consider iShares Nasdaq Biotechnology (IBB) and the SPDR S&amp;P Biotech (XBI). IBB has a bigger swath of the sector with 162 constituents in the index that it tracks, while XBI has 87.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/biotechnology\/biotechnology-gets-a-shot-in-the-arm-barrons-blog.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246860],"tags":[],"class_list":["post-1037540","post","type-post","status-publish","format-standard","hentry","category-biotechnology"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1037540"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1037540"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1037540\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1037540"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1037540"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1037540"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}